All In Biotech

Drug Trial Radar · NCT06995573

A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease

A Phase 2a, Multi-Center, Randomized, Parallel Group, Double Blind and Placebo-controlled Clinical Trial to Assess Safety and Tolerability as Well as Explorative Efficacy of the Orthosteric Selective Muscarinic M1 Agonist NSC001 in Mild to Moderate Alzheimer's Disease

Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Aug 25, 2025

Primary completion

Jul 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
NSC-TherapeuticsIndustry
Sponsor type
Industry
Collaborators
NeuroScios GmbH
First posted
May 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and tolerability of NSC001 on in patients with mild to moderate Alzheimer's disease and to evaluate the influence of the compound on cognitive function.

Conditions

  • Alzheimer Disease

Interventions

  • NSC001Drug

    rigid, orthosteric acetylcholine analog, highly specific for M1 muscarinic receptor

  • PlaceboOther

    matching placebo to NSC001

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of NSC001Time frame: Week 0 and week16
  2. Safety during the treatment periodTime frame: Week 0 and week16

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Medical University Innsbruck

    Innsbruck, Austria · Recruiting

  • Medical University Vienna

    Vienna, Austria · Recruiting

  • Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft GmbH

    Salzburg, State of Salzburg, Austria · Recruiting

  • University Hospital Graz

    Graz, Styria, Austria · Recruiting

  • Clinic Altenburger Land GmbH

    Altenburg, Germany · Not yet recruiting

  • Zentrum fuer klinische Forschung Dr. I. Schoell GmbH

    Bad Homburg, Germany · Recruiting

  • University Clinic Köln

    Cologne, Germany · Recruiting

  • Universitaetsmedizin Goettingen

    Göttingen, Germany · Recruiting

  • Dynamikos GmbH Institut fuer Studien zur Psychischen Gesundheit

    Mannheim, Germany · Recruiting

  • SANOS Clinic

    Ratingen, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.